Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学DLBCL, Marginal Zone Lymphoma

Catherine Thieblemont

MD

🏢Hopital Saint-Louis, University of Paris🌐France

Professor of Hematology

58
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Catherine Thieblemont at Saint-Louis Hospital in Paris is a leading French lymphoma expert and one of the principal investigators of glofitamab (CD20/CD3 bispecific antibody) trials in DLBCL. Her research on marginal zone lymphoma biology and treatment has contributed to understanding of this heterogeneous disease entity. She has been involved in multiple landmark lymphoma trials.

Share:

🧪Research Fields 研究领域

DLBCL
marginal zone lymphoma
glofitamab
bispecific antibodies
lymphoma biology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Catherine Thieblemont 的研究动态

Follow Catherine Thieblemont's research updates

留下邮箱,当我们发布与 Catherine Thieblemont(Hopital Saint-Louis, University of Paris)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment